Functional analysis of erythrocyte determinants of malaria infection
疟疾感染红细胞决定因素的功能分析
基本信息
- 批准号:8645599
- 负责人:
- 金额:$ 40.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-05-01 至 2016-04-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAnti-malarial drug resistanceAntimalarialsBinding ProteinsBiochemicalBiologicalBlood CirculationBlood Group AntigensBlood typing procedureCell surfaceCessation of lifeChildhoodClinicalCommunicable DiseasesDevelopmentDiseaseDrug resistanceEnvironmentErythrocytesGene TargetingGenesGeneticGenetic PolymorphismGenetic ScreeningGlycophorin AGoalsGrowthHematopoietic stem cellsHomologous ProteinHumanHuman PathologyImmuneIn VitroIndividualInfectionInterventionKnock-outLeadLifeLigandsMalariaMeasuresMembrane ProteinsMolecular GeneticsParasitesPathway interactionsPharmaceutical PreparationsPlasmodium falciparumPlayPopulationProcessProteinsRNA InterferenceRegimenRelative (related person)ResourcesReticulocytesRoleStem cellsSubfamily lentivirinaeSurfaceSystemVaccinesVariantWorkantigen bindingbaseblood groupcombinatorialdesignerythrocyte receptorgenetic analysisloss of functionloss of function mutationmembermortalitymutantnovelnovel strategiesnovel therapeuticsparasite invasionpositional cloningpublic health relevancereceptorresponsetherapeutic targetvaccine candidatevaccine development
项目摘要
DESCRIPTION (provided by applicant): Malaria remains a major global infectious disease, largely affecting people living in resource poor environments, and is one of the most important causes of childhood mortality. Drug-resistance is constantly undermining the usefulness of antimalarial regimens. There is an urgent need for the development of new therapeutic strategies. Plasmodium falciparum parasites utilize multiple ligand-receptor interactions for the invasion of human erythrocytes. Much work has focused on the characterization of parasite ligands, with the goal of developing them as vaccine candidates. Largely due to the genetic intractabiliy of enucleated human erythrocytes, the function of host human erythrocyte receptors in ligand-receptor interactions has not been comprehensively assessed. We have developed an approach combining an in vitro erythrocyte culture system, which supports P. falciparum invasion and growth, with lentiviral transduction to generate genetically modified erythrocytes. The best characterized ligand-receptor interaction in P. falciparum is that of the ligand EBA-175 and its receptor glycophorin A, with EBA-175 being developed as a vaccine candidate. Using this system, we have achieved knockdown in expression of glycophorin A, genetically demonstrating that it is required for efficient strain-specific parasite invasion. We hypothesize that targeting a limited number of erythrocyte receptors will be sufficient to abrogate P. falciparum invasion in all P. falciparum parasite lines. This project will functionally analyze erythrocyte determinants of the invasion process of P. falciparum. We will use 1) a loss-of- function approach to establish a hierarchy amongst putative erythrocyte receptors for invasion, 2) a combinatorial knockdown approach to identify minimal sets of erythrocyte surface determinants that are essential for invasion and 3) a genetic screen to identify human blood group antigens that are novel determinants of invasion. In the long-term we hope that our studies will provide a functional understanding of critical ligand-receptor interactions for P. falciparum invasion of erythrocytes to inform vaccine development and the design of host-targeted therapeutics.
描述(由申请人提供):疟疾仍然是一种主要的全球性传染病,主要影响生活在资源贫乏环境中的人们,并且是儿童死亡的最重要原因之一。抗药性不断破坏抗疟疗法的效用。迫切需要开发新的治疗策略。恶性疟原虫寄生虫利用多种配体-受体相互作用侵入人类红细胞。许多工作都集中在寄生虫配体的表征,其目标是将其开发为候选疫苗。主要由于去核人红细胞的遗传不稳定性,尚未全面评估宿主人红细胞受体在配体-受体相互作用中的功能。我们已经开发了一种方法,该方法将支持恶性疟原虫侵袭和生长的体外红细胞培养系统与慢病毒转导相结合,以产生遗传修饰的红细胞。恶性疟原虫中最具特征的配体-受体相互作用是配体EBA-175及其受体血型糖蛋白A的相互作用,EBA-175被开发为候选疫苗。使用该系统,我们已经实现了血型糖蛋白A表达的敲低,遗传上证明了它是有效的菌株特异性寄生虫入侵所必需的。我们假设靶向有限数量的红细胞受体将足以消除所有恶性疟原虫寄生虫系中的恶性疟原虫入侵。本项目将对恶性疟原虫侵袭过程中的红细胞决定因子进行功能分析。我们将使用1)功能丧失的方法来建立一个层次之间的推定红细胞受体的入侵,2)组合敲低的方法来确定最小集的红细胞表面决定因素是必不可少的入侵和3)遗传筛选,以确定人类血型抗原是新的入侵决定因素。从长远来看,我们希望我们的研究将提供对恶性疟原虫入侵红细胞的关键配体-受体相互作用的功能性理解,以告知疫苗开发和宿主靶向疗法的设计。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Manoj T Duraisingh其他文献
Hungry for control: metabolite signaling to chromatin in emPlasmodium falciparum/em
渴望控制:恶性疟原虫中代谢物向染色质的信号传导
- DOI:
10.1016/j.mib.2024.102430 - 发表时间:
2024-04-01 - 期刊:
- 影响因子:7.500
- 作者:
Ruth Lappalainen;Manish Kumar;Manoj T Duraisingh - 通讯作者:
Manoj T Duraisingh
Manoj T Duraisingh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Manoj T Duraisingh', 18)}}的其他基金
Malaria parasite determinants of host cell tropism
疟疾寄生虫宿主细胞趋向性的决定因素
- 批准号:
10646370 - 财政年份:2022
- 资助金额:
$ 40.38万 - 项目类别:
Evaluating host-directed therapeutics against blood-stage malaria parasites
评估针对血期疟疾寄生虫的宿主导向疗法
- 批准号:
10665779 - 财政年份:2022
- 资助金额:
$ 40.38万 - 项目类别:
Linking metabolite sensing and gene expression in malaria parasites
将疟疾寄生虫的代谢物传感和基因表达联系起来
- 批准号:
10593642 - 财政年份:2022
- 资助金额:
$ 40.38万 - 项目类别:
Evaluating host-directed therapeutics against blood-stage malaria parasites
评估针对血期疟疾寄生虫的宿主导向疗法
- 批准号:
10528133 - 财政年份:2022
- 资助金额:
$ 40.38万 - 项目类别:
Malaria parasite determinants of host cell tropism
疟疾寄生虫宿主细胞趋向性的决定因素
- 批准号:
10522253 - 财政年份:2022
- 资助金额:
$ 40.38万 - 项目类别:
Molecular basis of antimalarial drug resistance in Plasmodium vivax
间日疟原虫抗疟药物耐药性的分子基础
- 批准号:
10593992 - 财政年份:2022
- 资助金额:
$ 40.38万 - 项目类别:
Developing a barcoded malaria parasite panel to assess broadly neutralizing antibodies
开发带条形码的疟原虫面板来评估广泛中和抗体
- 批准号:
10655645 - 财政年份:2022
- 资助金额:
$ 40.38万 - 项目类别:
Comparative systems biology of apicomplexan cell division
顶端复合体细胞分裂的比较系统生物学
- 批准号:
10539938 - 财政年份:2022
- 资助金额:
$ 40.38万 - 项目类别:
Developing a barcoded malaria parasite panel to assess broadly neutralizing antibodies
开发带条形码的疟原虫面板来评估广泛中和抗体
- 批准号:
10511052 - 财政年份:2022
- 资助金额:
$ 40.38万 - 项目类别:
Comparative systems biology of apicomplexan cell division
顶端复合体细胞分裂的比较系统生物学
- 批准号:
10669790 - 财政年份:2022
- 资助金额:
$ 40.38万 - 项目类别:
相似海外基金
Plasmodium falciparum anti-malarial drug resistance in The Gambia:Identification of potential genetic markers by retrospective whole genome approaches
冈比亚的恶性疟原虫抗疟疾耐药性:通过回顾性全基因组方法鉴定潜在的遗传标记
- 批准号:
MC_EX_MR/K02440X/1 - 财政年份:2013
- 资助金额:
$ 40.38万 - 项目类别:
Fellowship














{{item.name}}会员




